How TFAM Affects Liver Damage from Acetaminophen
Author Information
Author(s): Chen Sisi, Cao Yaling, Fan Zihao, Xu Ling, Pan Zhenzhen, Gao Yao, Wei Linlin, Wei Qiaoxin, Tian Yuan, Zhang Xiangying, Liu Mei, Ren Feng
Primary Institution: Beijing Youan Hospital, Capital Medical University
Hypothesis
Depressed TFAM promotes acetaminophen-induced hepatotoxicity regulated by the DDX3X–PGC1α–NRF2 signaling pathway.
Conclusion
The study shows that low levels of TFAM in the liver contribute to liver damage from acetaminophen, and this is controlled by a specific signaling pathway.
Supporting Evidence
- TFAM expression was suppressed in AILI patients.
- TFAM overexpression alleviated liver necrosis and mitochondrial dysfunction.
- N-acetylcysteine treatment resulted in significant TFAM activation.
- DDX3X negatively regulates TFAM expression.
- Serum mtDNA levels were significantly higher in AILI patients.
Takeaway
When the liver is hurt by too much acetaminophen, a protein called TFAM gets low, which makes the damage worse. Fixing TFAM can help protect the liver.
Methodology
The study involved serum samples from patients and mouse models to assess TFAM expression and its effects on liver injury.
Potential Biases
Potential bias due to the limited sample size and the specific patient population.
Limitations
The study had a small number of liver tissue samples from patients due to the rapid progression of acute liver injury.
Participant Demographics
40 patients with acetaminophen-induced liver injury and 20 healthy controls.
Statistical Information
P-Value
p<0.001
Confidence Interval
95% CI 0.704–0.918
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website